Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Inventory Average (2016 - 2025)

Historic Inventory Average for Aytu Biopharma (AYTU) over the last 11 years, with Q4 2025 value amounting to $9.4 million.

  • Aytu Biopharma's Inventory Average fell 1782.33% to $9.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.4 million, marking a year-over-year decrease of 1782.33%. This contributed to the annual value of $11.8 million for FY2025, which is 232.43% down from last year.
  • Per Aytu Biopharma's latest filing, its Inventory Average stood at $9.4 million for Q4 2025, which was down 1782.33% from $10.8 million recorded in Q3 2025.
  • Aytu Biopharma's Inventory Average's 5-year high stood at $16.5 million during Q2 2021, with a 5-year trough of $9.4 million in Q4 2025.
  • Moreover, its 5-year median value for Inventory Average was $12.6 million (2023), whereas its average is $12.8 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 26472.13% in 2021, then plummeted by 2735.74% in 2022.
  • Aytu Biopharma's Inventory Average (Quarter) stood at $16.4 million in 2021, then fell by 21.45% to $12.9 million in 2022, then increased by 0.57% to $13.0 million in 2023, then dropped by 12.1% to $11.4 million in 2024, then dropped by 17.82% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q4 2025, $10.8 million for Q3 2025, and $11.2 million during Q2 2025.